UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 11,960 Shares of Molina Healthcare, Inc. (NYSE:MOH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Molina Healthcare, Inc. (NYSE:MOH) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 458,651 shares of the company’s stock after purchasing an additional 11,960 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.80% of Molina Healthcare worth $133,490,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of MOH. Colonial Trust Co SC boosted its stake in shares of Molina Healthcare by 930.0% during the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company’s stock valued at $30,000 after purchasing an additional 93 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter valued at about $52,000. Hurley Capital LLC bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $55,000. EverSource Wealth Advisors LLC lifted its position in shares of Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock worth $57,000 after purchasing an additional 88 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company’s stock valued at $58,000 after purchasing an additional 155 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on MOH. Robert W. Baird reaffirmed a “neutral” rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Wells Fargo & Company upgraded Molina Healthcare from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Baird R W cut Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Stephens reissued an “equal weight” rating and issued a $345.00 price target on shares of Molina Healthcare in a research note on Thursday, February 6th. Finally, UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a report on Friday, February 7th. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $365.38.

Insider Transactions at Molina Healthcare

In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. The trade was a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 89,169 shares of company stock worth $28,520,995 in the last 90 days. Insiders own 1.26% of the company’s stock.

Molina Healthcare Stock Down 1.6%

Molina Healthcare stock opened at $304.83 on Friday. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $365.23. The firm has a market capitalization of $16.52 billion, a price-to-earnings ratio of 14.92, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm’s fifty day moving average price is $324.45 and its two-hundred day moving average price is $308.09.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating analysts’ consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Molina Healthcare’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.73 EPS. On average, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.